Advertisement
Australia markets closed
  • ALL ORDS

    7,937.90
    +35.90 (+0.45%)
     
  • AUD/USD

    0.6451
    -0.0001 (-0.01%)
     
  • ASX 200

    7,683.50
    +34.30 (+0.45%)
     
  • OIL

    82.75
    +0.85 (+1.04%)
     
  • GOLD

    2,321.90
    -24.50 (-1.04%)
     
  • Bitcoin AUD

    102,568.02
    -11.89 (-0.01%)
     
  • CMC Crypto 200

    1,391.09
    -23.67 (-1.67%)
     

1 Reason to Sell Novavax Stock, and 1 Reason to Buy

This year hasn't been an easy one for Novavax (NASDAQ: NVAX) investors. After a series of stumbles culminating in its disastrous earnings report on Aug. 8, its shares are down by 60% so far in 2022. And with management slashing its full-year revenue guidance by roughly half, there isn't much hope for smoother sailing for at least a few quarters.